• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2300310 二甲双胍恩格列净片(VI) empagliflozin;metformin hydrochloride Tablet Chemical Drugs License Renew 2023-07-15 view
JYHZ2300309 二甲双胍恩格列净片(V) empagliflozin;metformin hydrochloride Tablet Chemical Drugs License Renew 2023-07-15 view
JYHZ2300308 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs License Renew 2023-07-15 view
JYHZ2300307 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs License Renew 2023-07-15 view
JYHZ2300306 二甲双胍恩格列净片(III) empagliflozin;metformin hydrochloride Tablet Chemical Drugs License Renew 2023-07-15 view
JYHZ2300305 二甲双胍恩格列净片(III) empagliflozin;metformin hydrochloride Tablet Chemical Drugs License Renew 2023-07-15 view
JYHB2200428 二甲双胍恩格列净片(ⅤI) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2200427 二甲双胍恩格列净片(Ⅴ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2200426 二甲双胍恩格列净片(IV) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2200425 二甲双胍恩格列净片(III) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2101090 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2021-05-11 Boehringer Ingelheim International GmbH view
JYHB2101089 二甲双胍恩格列净片(Ⅴ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2021-05-11 Boehringer Ingelheim International GmbH view
JYHB2002594 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-01-08 view
JYHB2002593 二甲双胍恩格列净片(Ⅴ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-01-08 view
JYHB2001001 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-07-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-08-21 view
JYHB2001000 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-07-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-08-21 view
JYHB2000799 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-07 view
JYHB2000798 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-07 view
JYHB2000705 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-16 view
JYHB2000704 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-16 view